Ben Landry is the General Counsel and Secretary of the Board, with responsibility for all aspects of legal and regulatory affairs at Health Catalyst, originally joining in July 2019 as Assistant General Counsel. Landry has ~15 years of private practice and in-house legal experience, primarily focused on healthcare and information technology. Prior to joining Health Catalyst, Landry worked at athenahealth, Inc. (NASDAQ: ATHN), a publicly traded healthcare IT company, for over 4 years in a variety of legal roles, including as Associate General Counsel, leading the corporate team that oversaw corporate governance, securities, mergers & acquisitions, strategic investments, international and other corporate functions. Landry helped support athenahealth's exploration of strategic alternatives in 2018 that ultimately led to closing a private equity-backed take-private transaction in February 2019, and helped lead aspects of post-transaction integration, including athenahealth's combination with another portfolio company owned by the acquirer.
Prior to joining athenahealth, Landry worked at a law firm in Boston for over 4 years, primarily focused on corporate, mergers & acquisitions and private equity, and worked at Raytheon Technologies Corporation (NYSE: RTX), a multinational aerospace and defense conglomerate, in the tax department. Landry received his bachelor's degree from Boston College and his law degree from the Northeastern University School of Law.
What is Benjamin Landry's net worth?
The estimated net worth of Benjamin Landry is at least $235.50 thousand as of December 5th, 2025. Mr. Landry owns 100,000 shares of Health Catalyst stock worth more than $235,500 as of December 19th. This net worth estimate does not reflect any other investments that Mr. Landry may own. Learn More about Benjamin Landry's net worth.
How do I contact Benjamin Landry?
Has Benjamin Landry been buying or selling shares of Health Catalyst?
During the past quarter, Benjamin Landry has sold $72,402.00 in Health Catalyst stock. Most recently, Benjamin Landry sold 27,425 shares of the business's stock in a transaction on Friday, December 5th. The shares were sold at an average price of $2.64, for a transaction totalling $72,402.00. Following the completion of the sale, the general counsel now directly owns 100,000 shares of the company's stock, valued at $264,000. Learn More on Benjamin Landry's trading history.
Who are Health Catalyst's active insiders?
Health Catalyst's insider roster includes Jason Alger (CAO), Daniel Burton (CEO), Duncan Gallagher (Director), Bryan Hinton (CTO), Paul Horstmeier (COO), Bryan Hunt (CFO), Benjamin Landry (General Counsel), Daniel LeSueur (COO), Linda Llewelyn (Insider), James Nelli, Jr. (President), Daniel Orenstein (CEO), and Anita Pramoda (Director). Learn More on Health Catalyst's active insiders.
Are insiders buying or selling shares of Health Catalyst?
During the last year, insiders at the sold shares 15 times. They sold a total of 163,602 shares worth more than $650,245.62. The most recent insider tranaction occured on December, 5th when General Counsel Benjamin Landry sold 27,425 shares worth more than $72,402.00. Insiders at Health Catalyst own 2.6% of the company.
Learn More about insider trades at Health Catalyst. Information on this page was last updated on 12/5/2025.